Amrutanjan Health Care Ltd
Thu 27/08/2026,15:55:18 | NSE : AMRUTANJAN
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 527.00
Previous Close
₹ 527.75
Volume
93176
Mkt Cap ( ₹ Cr)
₹ 1494.82
High
₹ 527.75
Low
₹ 506.55
52 Week High
₹ 790.95
52 Week Low
₹ 482.80
Book Value Per Share
₹ 129.57
Dividend Yield
0.92
Face Value
₹ 1.00
What's Your Call?
Collective community sentiment on Amrutanjan Health Care Ltd
Your Vote -
Buy
95.10%
Hold
2.94%
Sell
1.96%
95.10%
102 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
0%
Sell Order Quantity
100%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
517.05
102
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
102
Option Chain
Analyzes market sentiment, predicts Amrutanjan Health Care Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Amrutanjan Health Ca has declared 290% Final dividend for the financial year March 2026
-
Amrutanjan Health Ca - Investor Presentation For The Quarter Ended 30Th June 2026
-
Amrutanjan Health Ca - Investor Presentation
-
Amrutanjan Health Ca - Record Date For The Final Dividend And AGM
-
Amrutanjan Health Ca - Record Date
-
Amrutanjan Health Ca - Outcome of Board Meeting
-
Amrutanjan Health Ca - Board Meeting Outcome for Financial Results And Outcome Of The Board Meeting
-
Amrutanjan Health Ca - Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regula
-
Amrutanjan Health Ca - Commencement of commercial production/operations
-
Amrutanjan Health Ca - Credit Rating
-
Amrutanjan Health Ca - Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results For The Quarter E
-
Amrutanjan Health Ca - Commissioning Of New Manufacturing Facility
-
Amrutanjan Health Ca - Announcement under Regulation 30 (LODR)-Credit Rating
-
Amrutanjan Health Ca - Intimation Of Under Regulation 30 Read With Clause 20 Of Para A Of Part A Of Schedule Ill Of SEBI (Lis
-
Amrutanjan Health Ca - Action(s) taken or orders passed
-
Amrutanjan Health Ca has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026
-
Amrutanjan Health Ca - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Amrutanjan Health Ca - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Amrutanjan Health Ca - Trading Window
-
Amrutanjan Health Ca - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
-
Amrutanjan Health Ca - General Updates
-
Amrutanjan Health Ca - Shareholders meeting
-
Amrutanjan Health Ca - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Amrutanjan Health Ca - Reconstitution Of Committees Of Board Of Directors.
-
Amrutanjan Health Ca - Updates
-
Amrutanjan Health Care surges as board nod buyback of shares
-
Amrutanjan Heath Care signs up with Amazon
Key fundamentals
Evaluate the intrinsic value of Amrutanjan Health Care Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 370.2326 | 326.6146 | 288.4883 | 290.7719 | 265.1238 |
| Liabilities | 370.2326 | 326.6146 | 288.4883 | 290.7719 | 265.1238 |
| Equity | 2.8911 | 2.8911 | 2.8911 | 2.9231 | 2.9231 |
| Gross Profit | 75.6846 | 58.2006 | 51.8114 | 44.3923 | 79.4738 |
| Net Profit | 57.9178 | 50.8347 | 44.9726 | 39.8349 | 67.1889 |
| Cash From Operating Activities | 35.9677 | 50.8992 | 27.9106 | 20.181 | 52.1956 |
| NPM(%) | 11.52 | 11.25 | 10.67 | 10.49 | 16.55 |
| Revenue | 502.5527 | 451.8163 | 421.2305 | 379.636 | 405.8424 |
| Expenses | 426.8681 | 393.6157 | 369.4191 | 335.2437 | 326.3686 |
| ROE(%) | 15.46 | 13.57 | 12 | 10.63 | 17.93 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 11 Sep 2026 | 2.9 | 290 | 0.95 | 548.55 |
| 06 Feb 2026 | 1 | 100 | 0.95 | 582.7 |
| 18 Nov 2025 | 1 | 100 | 0.95 | 704 |
| 16 Sep 2025 | 2.6 | 260 | 0.95 | 717.1 |
| 18 Feb 2025 | 1 | 100 | 0.95 | 621.7 |
| 22 Nov 2024 | 1 | 100 | 0.95 | 743.65 |
| 13 Sep 2024 | 2.6 | 260 | 0.95 | 736.55 |
| 20 Feb 2024 | 1 | 100 | 0.95 | 572.85 |
| 24 Feb 2023 | 1 | 100 | 0.95 | 710.9 |
| 14 Sep 2022 | 2.6 | 260 | 0.95 | 824.4 |
| 18 Feb 2022 | 1 | 100 | 0.95 | 853.5 |
| 16 Nov 2021 | 1 | 100 | 0.95 | 923.45 |
| 15 Sep 2021 | 2.6 | 260 | 0.95 | 760.45 |
| 17 Feb 2021 | 0.8 | 80 | 0.95 | 519.45 |
| 19 Nov 2020 | 0.8 | 80 | 0.95 | 427.35 |
| 18 Feb 2020 | 1.55 | 155 | 0.95 | 481.2 |
| 15 Nov 2019 | 0.55 | 55 | 0.95 | 409.8 |
| 17 Sep 2019 | 1.05 | 105 | 0.95 | 283.65 |
| 20 Feb 2019 | 0.55 | 55 | 0.95 | 312 |
| 12 Nov 2018 | 0.55 | 55 | 0.95 | 244.45 |
| 07 Sep 2018 | 0.85 | 85 | 0.95 | 280.55 |
| 22 Feb 2018 | 1.1 | 55 | 0.95 | 590.75 |
| 16 Nov 2017 | 1.1 | 55 | 0.95 | 590.55 |
| 13 Sep 2017 | 1.65 | 82.5 | 0.95 | 767.9 |
| 16 Feb 2017 | 1.1 | 55 | 0.95 | 605.35 |
| 17 Nov 2016 | 1.1 | 55 | 0.95 | 576.15 |
| 18 Mar 2016 | 2.65 | 132.5 | 0.95 | 406.6 |
| 17 Feb 2016 | 1.2 | 60 | 0.95 | 422.65 |
| 10 Sep 2015 | 2.4 | 120 | 0.95 | 483.65 |
| 13 Feb 2015 | 1.1 | 55 | 0.95 | 430.15 |
| 17 Sep 2014 | 2.2 | 110 | 0.95 | 155.55 |
| 17 Feb 2014 | 1 | 50 | 0.95 | 132.2 |
| 02 Aug 2013 | 2 | 100 | 0.95 | 132.85 |
| 21 Feb 2013 | 1 | 50 | 0.95 | 141.55 |
| 20 Sep 2012 | 10 | 100 | 0.95 | 772.6 |
| 23 Feb 2012 | 5 | 50 | 0.95 | 818.15 |
| 12 Sep 2011 | 10 | 100 | 0.95 | 831.45 |
| 21 Feb 2011 | 5 | 50 | 0.95 | 560.2 |
| 13 Aug 2010 | 10 | 100 | 0.95 | 807.15 |
| 09 Feb 2010 | 5 | 50 | 0.95 | 545.35 |
Peers
Other companies within the same industry or sector that are comparable to Amrutanjan Health Care Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 890.25 | 2.36 | 22.52 | 301.57 | -26.19 | 0.56 |
| Lotus Eye Hospital and Institute Ltd | 112.63 | 0.91 | 1609.00 | 1098.88 | 0.39 | 0.00 |
| Vaishali Pharma Ltd | 8.33 | 1.96 | 26.03 | 6893.62 | 15.42 | 0.00 |
| Astec Lifesciences Ltd | 585.90 | -1.28 | 0.00 | 1177.39 | -363.14 | 0.00 |
Company Info
The Company was incorporated in 1936. The company manufactures, Amrutanjan pain balm, Anoleum, Gripe Water, Inhaler, Dermal Ointment, Cetomix cough mixture, Castor Oil, Swas Mints 'Salofin' tablets, Amrutanjan cold rub, 'Hero' Super Pain Balm, Dragon Liquid Balm. The company has concluded an arrangement for marketing of "Gelax" and Anchor brands of Isabgol with M/s Unjha Formulations in southern states as well as North Eastern parts of the country. Amrutanjan Leasing & Finance Ltd & Amrutanjan Fine Chemicals Ltd are the subsidiary companies. 2001- Amrutanjan has announced a liberal bonus issue by capitalising Rs 1.6 crore reserve for the benefit of small shareholders. 2004 -Winds up its printing and packaging arm, Egattur Printing and Packaging Ltd 2007 - Company name has been changed from Amrutanjan Ltd to Amrutanjan Health Care Ltd. 2009 - Amrutanjan Health Care Ltd has informed that the Board of Directors of the Company at its meeting held on June 25, 2009 has co-opted Mr. A Satish Kumar as an Additional Director of the Company under Section 260 of the Companies Act, 1956 with effect from June 25, 2009. 2010 -Amrutanjan Health recommend payment of Final Dividend of Rs. 10/- per share (100%) on the Equity Share 2011 -Amrutanjan acquires Fruitnik for Rs 26.2 crore 2012 -Amrutanjan Health Care has recommended a Final Dividend of Rs. 10/- per share -Company has splits its Face value of Shares from Rs 10 to Rs 2. 2013 -Board has recommended a Final Dividend of Rs. 2/- per share. 2014 -Board has recommended a Final Dividend of Rs. 2.20/- (110%) per share. 2016 -Amrutanjan Health Care Limited has informed that the Scheme of Amalgamation of M/s. Amrutanjan Pharmaessense Private Limited (Transferor) with M/s. Amrutanjan Health Care Limited (Transferee) was approved by the National Company law Tribunal (NCLT) , Chennai 2017 -Company Informed to exchange that NCLT has approved the Amalgamation of Amrutanjan Pharmaessense Private Limited with M/s. Amrutanjan Health Care Limited. 2018 -The Company has splits its face value from Rs. 2/- to Rs. 1/-. -Company Won Best Brand Leadership Awards, 2018.
The Company was incorporated in 1936. The company manufactures, Amrutanjan pain balm, Anoleum, Gripe Water, Inhaler, Dermal Ointment, Cetomix cough mixture, Castor Oil, Swas Mints 'Salofin' tablets, Amrutanjan cold rub, 'Hero' Super Pain Balm, Dragon Liquid Balm. The company has concluded an arrangement for marketing of "Gelax" and Anchor brands of Isabgol with M/s Unjha Formulations in southern states as well as North Eastern parts of the country. Amrutanjan Leasing & Finance Ltd & Amrutanjan Fine Chemicals Ltd are the subsidiary companies. 2001- Amrutanjan has announced a liberal bonus issue by capitalising Rs 1.6 crore reserve for the benefit of small shareholders. 2004 -Winds up its printing and packaging arm, Egattur Printing and Packaging Ltd 2007 - Company name has been changed from Amrutanjan Ltd to Amrutanjan Health Care Ltd. 2009 - Amrutanjan Health Care Ltd has informed that the Board of Directors of the Company at its meeting held on June 25, 2009 has co-opted Mr. A Satish Kumar as an Additional Director of the Company under Section 260 of the Companies Act, 1956 with effect from June 25, 2009. 2010 -Amrutanjan Health recommend payment of Final Dividend of Rs. 10/- per share (100%) on the Equity Share 2011 -Amrutanjan acquires Fruitnik for Rs 26.2 crore 2012 -Amrutanjan Health Care has recommended a Final Dividend of Rs. 10/- per share -Company has splits its Face value of Shares from Rs 10 to Rs 2. 2013 -Board has recommended a Final Dividend of Rs. 2/- per share. 2014 -Board has recommended a Final Dividend of Rs. 2.20/- (110%) per share. 2016 -Amrutanjan Health Care Limited has informed that the Scheme of Amalgamation of M/s. Amrutanjan Pharmaessense Private Limited (Transferor) with M/s. Amrutanjan Health Care Limited (Transferee) was approved by the National Company law Tribunal (NCLT) , Chennai 2017 -Company Informed to exchange that NCLT has approved the Amalgamation of Amrutanjan Pharmaessense Private Limited with M/s. Amrutanjan Health Care Limited. 2018 -The Company has splits its face value from Rs. 2/- to Rs. 1/-. -Company Won Best Brand Leadership Awards, 2018.
Read More
Parent Organisation
Amrutanjan Health Care Ltd.
Founded
09/09/1936
Managing Director
Mr.S Sambhu Prasad
NSE Symbol
AMRUTANJANEQ
FAQ
The current price of Amrutanjan Health Care Ltd is ₹ 517.05.
The 52-week high for Amrutanjan Health Care Ltd is ₹ 527.75 and the 52-week low is ₹ 506.55.
The market capitalization of Amrutanjan Health Care Ltd is currently ₹ 1494.82. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Amrutanjan Health Care Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Amrutanjan Health Care Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Amrutanjan Health Care Ltd shares.
The CEO of Amrutanjan Health Care Ltd is Mr.S Sambhu Prasad, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
